157
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Distinct immune-response profile of Richter transformation chronic lymphocytic leukemia (CLL), defined by high expression of PD1, LAG3, TIM3 and IL-10

, , , &
Pages 3222-3226 | Received 09 Jun 2022, Accepted 28 Aug 2022, Published online: 14 Sep 2022
 

Acknowledgements

The authors acknowledge all the patients that were included in the study. The authors are thankful to David Dittmann for his help with next-generation sequencing.

Author contributions

QC, and AB designed the study, collected and analyzed data, wrote the manuscript, and approved the final version. MS analyzed data and helped with the manuscript. YC and SM revised the manuscript and approved the final version.

Disclosure statement

AB has received honorarium for speaker bureau from Eli Lilly, Foundation Medicine/Roche China, Thermo Fisher scientific and Bayer. SM has Research Funding: Loxo; AstraZeneca; Juno; BeiGene; Abbvie; Janssen; TG Therapeutics; Pharmacyclics; Consultancy: AstraZeneca; Abbvie, BeiGene, Janssen, TG Therapeutics; Speakers Bureau: AstraZeneca; BeiGene; Janssen; Pharmacyclics.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.